News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Positive ctDNA predicts metastasis in MIBC after TMT
24 Feb 2026
byStephen Padilla
Plasma circulating tumour DNA (ctDNA) can act as a biomarker for the early detection of metastatic progression in patients with muscle-invasive bladder cancer (MIBC) treated with bladder-sparing trimodality therapy (TMT), suggests a study.

![[Infographics] DESTINY-Gastric04: Superior OS with 2L T-DXd in HER2+ metastatic GC/GEJA](https://cdn.mspprd.mims.com/images/articles/hk-dai-180mo00-80d45d41-b2f3-498d-a68f-9874576155c2-square.jpg)






